Nyrada Inc

  • IPO date:
  • Sector: Healthcare
  • GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
  • Industry: Biotechnology
  • Company website

Company description

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurodegenerative diseases. Its products in the drug development stage includes PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; and neuroprotectant drug to reduce the disability in patients with traumatic brain injury and ischaemic stroke. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia.

Financial highlights

Market Capitalization$4.2122 million
P/E Ratio0
P/E Growth Ratio
Book Value0.027
Dividend Per Share0
Earnings Per Share-0.02
EBITDA-7,775.158
Profit Margin0
Operating Margin TTM-4.9291
Return on Assets TTM-0.5662
Return on Equity TTM-0.9877
Revenue TTM1,578.722

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
2018-06-30 4.09 689.52 -689.52 2,182.074
2019-06-30 505.7 1,041.201 -554.863 3,949.928
2020-06-30 1,075.41 6,758.726
2021-06-30 2,340.01 5,873.659
2022-06-30 1,107.57 5,065.849
2023-06-30 1,578.72 9,360.414

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
2018-06-30 3,108.197 3,170.27 4,532.94 0 3,279.45 37.003
2019-06-30 7,515 7,555 327 3,930.35 0 15,840
2020-06-30 5,146.169 6,267.268 740.668 0 15,607.349
2021-06-30 13,750.743 15,157.007 665.381 0 25,320.332
2022-06-30 10,816.039 12,014.394 515.478 0 25,320.332
2023-06-30 3,708.761 5,164.722 906.284 25,320.332

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
2018-06-30 -2,416.276 -690.181 3,108.197
2019-06-30 -4,095.13 -2,005.359 -2,005.8 1,102.397
2020-06-30 -5,773.667 -4,410.623 4,043.772 1,102.397 5,146.169 1,719.378
2021-06-30 -3,539.253 -2,772.848 8,604.574 5,146.169 13,750.743
2022-06-30 -3,961.047 -3,956.313 -2,934.704 13,750.743 10,816.039
2023-06-30 -7,781.692 -7,199.39 -7,107.278 10,816.039 3,708.761